PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)75481-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)75481-4/fulltext
Title :
PMS5 COST-EFFECTIVENESS OF THE USE OF ETANERCEPT VS ANTI-TNF MONOCLONAL ANTIBODIES IN PATIENTS WITH RHEUMATOID ARTHRITIS IN MEXICO
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)75481-4&doi=10.1016/S1098-3015(10)75481-4
First page :
Section Title :
Open access? :
No
Section Order :
1406